CR2

OMIMHGNC

Synonym(s): CD21, C3DR

Locus: 1q32.2

Protein: Complement receptor type 2

 

Disorders

Tests

Test Type
Molecular (12)
Multi-Gene Panel (7)
Multi-Method Panel (5)
Test Method
Del/Dup (CNV) (6)
Sequencing, Capillary (Sanger) (3)
Sequencing, Next Gen (9)
Prenatal/Carrier
Prenatal (5)
Carrier (7)
Lab Location
Portugal(3)
USA(4)
Spain(1)
Germany(2)
Finland(2)
 
Primary Antibody Deficiency Panel, Sequencing (35 Genes) and Deletion/Duplication (26 Genes)
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen 
ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA
Immunodeficiency common variable 7 (sequence analysisof CR2 gene)
method(s): ◦ Sequencing, Next Gen 
CGC Genetics - Porto, Portugal
TAT: 4-6 weeks
price: contact lab
Antibody Deficiencies Panel
method(s): ◦ Sequencing, Next Gen 
CeGaT GmbH - Tübingen, Germany
Common Variable Immune Deficiency and Related Disorders, Panel Massive Sequencing (NGS) 51 Genes
method(s): ◦ Sequencing, Next Gen 
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain
TAT: 11-12 weeks
price: contact lab
CR2 Gene Sequencing
method(s): ◦ Sequencing, Capillary (Sanger) 
Cincinnati Children's Hospital Medical Center, Molecular Genetics Laboratory - Cincinnati, OH, USA
TAT: 4 weeks
price: contact lab
CR2 Deletion/duplication analysis
method(s): ◦ Del/Dup (CNV) 
Cincinnati Children's Hospital Medical Center, Molecular Genetics Laboratory - Cincinnati, OH, USA
TAT: 4-5 Weeks
price: contact lab
CR2
method(s): ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) 
Fulgent Diagnostics - Temple City, CA, USA
Predominantly antibody deficiencies: recurrent bacterial infections – all subtypes (NGS panel of 28 genes)
method(s): ◦ Sequencing, Next Gen 
CGC Genetics - Porto, Portugal
Predominantly antibody deficiencies: recurrent bacterial infections – significant reduction of IgG, IgA and/or IgM antibodies (NGS panel of 20 genes)
method(s): ◦ Sequencing, Next Gen 
CGC Genetics - Porto, Portugal
TAT: 3-4 weeks
price: contact lab
Primary Immunodeficiency Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen 
Blueprint Genetics - Helsinki, Finland
TAT: 3-4 weeks
price: contact lab
Complement System Disorder Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen 
Blueprint Genetics - Helsinki, Finland
TAT: ~2 weeks
price: contact lab
Immunodeficiency, common variable type 7
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) 
Centogene AG, Rare Disease Company - Rostock, Germany